Nasus Pharma NSRX Ratios (2024-2025)

NYSE NSRX
$3.85 +0.01 (+0.26%)
At close: Aug 20, 2026 · 4:00 PM EDT
Ratios Dec2024 Jun2025 Dec2025
Efficiency
Assets Average (Quarter) 0.68M2.82M
Invested Capital (Quarter) 1.80M2.56M
Leverage & Solvency
Debt Ratio (Quarter) 2.514.01
Valuation
Enterprise Value (Quarter) -0.31M-0.23M-4.34M